MEHP promotes breast cancer progression via GPR30-mediated epithelial–mesenchymal transition
Food and Chemical Toxicology · 2026-06 · 212 · 116049
DOI: 10.1016/j.fct.2026.116049 ↗Kurz gefasst
Fachartikel in der Zeitschrift Food and Chemical Toxicology, 2026-06. Verfasst von Wen Qi und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Occupational and Environmental Health, School of Public Health, Jilin University, Changchun, China. Hauptthemen laut MEDLINE: Receptors, G-Protein-Coupled, Diethylhexyl Phthalate, Epithelial-Mesenchymal Transition, Breast Neoplasms. Die Arbeit nennt 47 Literaturangaben. Gefördert von: Jilin Provincial Science and Technology Department, Jilin Provincial Scientific and Technological Development Program.
Abstract (Originalsprache)
PURPOSE Mono-(2-ethylhexyl) phthalate (MEHP), the primary metabolite of di-(2-ethylhexyl) phthalate (DEHP), is a well-documented environmental endocrine disruptor with estrogen-like effects that promote the development of hormone receptor-positive tumors. G protein-coupled receptor 30 (GPR30), also known as G protein-coupled estrogen receptor 1, has emerged as a key factor in the pathogenesis and progression of hormone-dependent tumors. This study elucidates the mechanism by which MEHP promotes breast cancer development via GPR30. METHODS MCF-7 cells were exposed to different concentrations of MEHP, and GPR30 expression was inhibited using G15. Cell proliferation and cell cycle were assessed using the CCK-8 and flow cytometry, respectively. Cell migration and cell invasion was evaluated via scratch-wound assays and transwell migration assay. Western blotting and quantitative real-time reverse transcription PCR were performed to analyze the expression of GPR30 and epithelial-mesenchyme transition (EMT)-related mRNAs and proteins. RESULTS Our findings demonstrate that MEHP exposure promotes the proliferation, migration, and invasion of MCF-7 cells, while concomitantly modulating the expression of GPR30, cell cycle-related and EMT-associated mRNAs and proteins. After inhibiting GPR30, the promoting effect of MEHP on MCF-7 cell proliferation and migration decreased. CONCLUSION Notably, GPR30 inhibition attenuated MEHP-induced promotion of MCF-7 cell proliferation and migration through modulating of EMT process.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Occupational and Environmental Health, School of Public Health, Jilin University, Changchun, China.
- Department of Radiotherapy, Tumor Hospital of Jilin Province, Changchun, China.
- NHC Key Laboratory of Radiobiology, School of Public Health, Jilin University, Changchun, China. Electronic address: jinsz@jlu.edu.cn.
- Department of Occupational and Environmental Health, School of Public Health, Jilin University, Changchun, China. Electronic address: jlyelin@163.com.
Förderung
- Jilin Provincial Science and Technology Department
- Jilin Provincial Scientific and Technological Development Program
Zitieren
APA
Qi, W., Wang, J., Wang, Y., Cui, J., Wu, X., Ding, Z., Jiang, T., Liu, W., Zhai, X., Jin, S., & Ye, L. (2026). MEHP promotes breast cancer progression via GPR30-mediated epithelial–mesenchymal transition. Food and Chemical Toxicology, 212, 116049. https://doi.org/10.1016/j.fct.2026.116049
Vancouver
Qi W, Wang J, Wang Y, Cui J, Wu X, Ding Z, et al. MEHP promotes breast cancer progression via GPR30-mediated epithelial–mesenchymal transition. Food and Chemical Toxicology. 2026;212:116049. doi:10.1016/j.fct.2026.116049
BibTeX
@article{Qi2026,
author = {Qi, Wen and Wang, Jia and Wang, Yunlong and Cui, Jianwei and Wu, Xiaotong and Ding, Ziji and Jiang, Tao and Liu, Wanyu and Zhai, Xueyu and Jin, Shunzi and Ye, Lin},
title = {MEHP promotes breast cancer progression via GPR30-mediated epithelial–mesenchymal transition},
journal = {Food and Chemical Toxicology},
year = {2026},
volume = {212},
pages = {116049},
doi = {10.1016/j.fct.2026.116049}
}
EUVIMED